Combinatorial approach to treat iron overload cardiomyopathy in pediatric patients with thalassemia-major: A systematic review and meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-2)

Sum=0

Feb 26, 2025 (publication date) through Feb 25, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Feb 26, 2025; 17(2): 103733
Published online Feb 26, 2025. doi: 10.4330/wjc.v17.i2.103733

Table 2 Summary of the iron chelators used in the studies included in the analysis, n (%)

DFO: Deferoxamine; DFX: Deferasirox; DFP: Deferiprone.

Citation: Safwan M, Bourgleh MS, Alsudays A, Haider KH. Combinatorial approach to treat iron overload cardiomyopathy in pediatric patients with thalassemia-major: A systematic review and meta-analysis. World J Cardiol 2025; 17(2): 103733
URL: https://www.wjgnet.com/1949-8462/full/v17/i2/103733.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i2.103733